FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Lamotrigine Tablets
Status: Discontinuation
»Therapeutic Categories: Neurology

Expand all

Mylan Pharmaceuticals Inc. (New 11/28/2017)

Company Contact Information:
800-RXMYLAN (1-800-496-9526)

Presentation Posting Date Related Information
Lamotrigine Tablets 100 mg (NDC 0378-4252-01)(NDC 0378-4252-05) 11/28/2017 Discontinuation of the manufacture of the drug product.
Lamotrigine Tablets 25 mg (NDC 0378-4251-01) 11/28/2017 Discontinuation of the manufacture of the drug product.
Lamotrigine Tablets 150 mg (NDC 0378-4253-91)(NDC 0378-4253-05) 11/28/2017 Discontinuation of the manufacture of the drug product.
Lamotrigine Tablets 200 mg (NDC 0378-4254-91)(NDC 0378-4254-05) 11/28/2017 Discontinuation of the manufacture of the drug product.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English